Beta-nicotinamide Adenine Dinucleotide is an Inhibitory Neurotransmitter in Visceral Smooth Muscle.

Violeta N. Mutafova-Yambolieva,Sung Jin Hwang,Xuemei Hao,Hui Chen,Michael X. Zhu,Jackie D. Wood,Sean M. Ward,Kenton M. Sanders
DOI: https://doi.org/10.1073/pnas.0705510104
2007-01-01
Abstract:Peripheral inhibitory nerves are physiological regulators of the contractile behavior of visceral smooth muscles. One of the transmitters responsible for inhibitory neurotransmission has been reputed to be a purine, possibly ATP. However, the exact identity of this substance has never been verified. Here we show that β-nicotinamide adenine dinucleotide (β-NAD), an inhibitory neurotransmitter candidate, is released by stimulation of enteric nerves in gastrointestinal muscles, and the pharmacological profile of β-NAD mimics the endogenous neurotransmitter better than ATP. Levels of β-NAD in superfusates of muscles after nerve stimulation exceed ATP by at least 30-fold; unlike ATP, the release of β-NAD depends on the frequency of nerve stimulation. β-NAD is released from enteric neurons, and release was blocked by tetrodotoxin or ω-conotoxin GVIA. β-NAD is an agonist for P2Y1 receptors, as demonstrated by receptor-mediated responses in HEK293 cells expressing P2Y1 receptors. Exogenous β-NAD mimics the effects of the enteric inhibitory neurotransmitter. Responses to β-NAD and inhibitory junction potentials are blocked by the P2Y1-selective antagonist, MRS2179, and the nonselective P2 receptor antagonists, pyridoxal phosphate 6-azophenyl-2′,4′-disulfonic acid and suramin. Responses to ATP are not blocked by these P2Y receptor inhibitors. The expression of CD38 in gastrointestinal muscles, and specifically in interstitial cells of Cajal, provides a means of transmitter disposal after stimulation. β-NAD meets the traditional criteria for a neurotransmitter that contributes to enteric inhibitory regulation of visceral smooth muscles.
What problem does this paper attempt to address?